Morgan Stanley’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $720K | Sell |
213,550
-34,328
| -14% | -$116K | ﹤0.01% | 5275 |
|
|
2025
Q1 | $957K | Sell |
247,878
-98,305
| -28% | -$379K | ﹤0.01% | 5020 |
|
|
2024
Q4 | $2.14M | Sell |
346,183
-82,615
| -19% | -$510K | ﹤0.01% | 4649 |
|
|
2024
Q3 | $2.31M | Buy |
428,798
+39,361
| +10% | +$212K | ﹤0.01% | 4546 |
|
|
2024
Q2 | $1.3M | Sell |
389,437
-88,655
| -19% | -$297K | ﹤0.01% | 4813 |
|
|
2024
Q1 | $1.93M | Sell |
478,092
-608,870
| -56% | -$2.45M | ﹤0.01% | 4611 |
|
|
2023
Q4 | $2.88M | Buy |
1,086,962
+726,704
| +202% | +$1.93M | ﹤0.01% | 4737 |
|
|
2023
Q3 | $850K | Buy |
360,258
+169,490
| +89% | +$400K | ﹤0.01% | 4893 |
|
|
2023
Q2 | $1.2M | Buy |
190,768
+121,391
| +175% | +$765K | ﹤0.01% | 4727 |
|
|
2023
Q1 | $400K | Buy |
69,377
+27,953
| +67% | +$161K | ﹤0.01% | 5379 |
|
|
2022
Q4 | $425K | Sell |
41,424
-17,511
| -30% | -$180K | ﹤0.01% | 5324 |
|
|
2022
Q3 | $985K | Buy |
58,935
+20,103
| +52% | +$336K | ﹤0.01% | 4892 |
|
|
2022
Q2 | $544K | Buy |
38,832
+26,016
| +203% | +$364K | ﹤0.01% | 5372 |
|
|
2022
Q1 | $207K | Sell |
12,816
-488
| -4% | -$7.88K | ﹤0.01% | 5906 |
|
|
2021
Q4 | $285K | Buy |
13,304
+5,900
| +80% | +$126K | ﹤0.01% | 5873 |
|
|
2021
Q3 | $108K | Buy |
7,404
+6,757
| +1,044% | +$98.6K | ﹤0.01% | 6320 |
|
|
2021
Q2 | $13K | Buy |
+647
| New | +$13K | ﹤0.01% | 7149 |
|